• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

朝着开发羧肽酶G2(卡泊酸酶)的生物类似物变体迈进:分泌表达、优化及固定化

Toward the Development of a Biosimilar Variant of Glucarpidase (Carboxypeptidase G2): Secretory Production, Optimization, and Immobilization.

作者信息

Moradbeygi Fatemeh, Ghoshoon Mohammad Bagher, Sadeghian Issa, Moradi Anahita, Ghasemi Younes, Morowvat Mohammad Hossein, Hemmati Shiva

机构信息

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Mol Biotechnol. 2025 Jun 4. doi: 10.1007/s12033-025-01450-4.

DOI:10.1007/s12033-025-01450-4
PMID:40465023
Abstract

Carboxypeptidase G2 (CPG2) detoxifies high-dose methotrexate in cancer or autoimmune therapies. Additionally, CPG2 activates prodrugs at the tumor site in engineered CAR-T cell therapy. Since CPG2 cleaves glutamate from the substrate, it also has potential applications in enhancing food flavors and developing biosensors. However, cytoplasmic expression of recombinant CPG2 often leads to inclusion body formation, necessitating secretory production to improve product quality and streamline downstream industrial processes. This study aimed to perform a comprehensive in silico analysis to identify an optimal signal peptide for CPG2 secretion. The pelB leader sequence was selected for excretory production using the pET22b vector in Escherichia coli. The enzyme was successfully secreted into both the periplasmic space of bacterial cells and the culture medium with activities of about 0.038 UmL and 0.0285 UmL, respectively. Optimal expression conditions were achieved at 25 °C with 0.5-mM IPTG, leading to enhanced yields. In the second step, we aimed to optimize the culture media composition. Therefore, a statistical design of experiments (DOE) approach in Modde software was conducted, evaluating eleven variables via a fractional factorial design (FFD). A central composite face (CCF) design was applied to establish an empirical model for maximizing periplasmic CPG2 production. The final aim was to immobilize the whole E. coli cells in calcium alginate beads for higher metabolic activity, improved growth rates, and plasmid stability. Engineered bacterial cells were entrapped in a mixture of sodium alginate and calcium chloride solution and incubated at 4 °C, 400 rpm for 60 min. Immobilization of CPG2-producing E. coli cells in 2% (w/v) calcium alginate beads yielded spherical beads, maintaining enzyme stability for 10 days, with peak activity on day 5. Conclusively, improved CPG2 solubility, facilitated protein purification, and enzyme stability over multiple reaction cycles offer a cost-effective solution for industrial purposes.

摘要

羧肽酶G2(CPG2)可在癌症或自身免疫疗法中使高剂量甲氨蝶呤解毒。此外,在工程化嵌合抗原受体T细胞(CAR-T)疗法中,CPG2可在肿瘤部位激活前药。由于CPG2能从底物上切割下谷氨酸,它在增强食品风味和开发生物传感器方面也具有潜在应用。然而,重组CPG2的胞质表达常常导致包涵体形成,因此需要进行分泌表达以提高产品质量并简化下游工业流程。本研究旨在进行全面的计算机模拟分析,以确定用于CPG2分泌的最佳信号肽。使用pET22b载体在大肠杆菌中选择pelB前导序列进行分泌表达。该酶成功分泌到细菌细胞的周质空间和培养基中,活性分别约为0.038 U/mL和0.0285 U/mL。在25℃和0.5 mM异丙基-β-D-硫代半乳糖苷(IPTG)条件下实现了最佳表达条件,从而提高了产量。在第二步中,我们旨在优化培养基组成。因此,在Modde软件中采用实验设计(DOE)方法,通过分式析因设计(FFD)评估11个变量。应用中心复合表面(CCF)设计建立了一个用于最大化周质CPG2产量的经验模型。最终目标是将整个大肠杆菌细胞固定在海藻酸钙珠中,以实现更高的代谢活性、更快的生长速率和质粒稳定性。将工程化细菌细胞包埋在海藻酸钠和氯化钙溶液的混合物中,于4℃、400 rpm孵育60分钟。将产生CPG2的大肠杆菌细胞固定在2%(w/v)海藻酸钙珠中可得到球形珠,酶稳定性维持10天,第5天活性达到峰值。总之,提高CPG2的溶解度、促进蛋白质纯化以及在多个反应循环中保持酶稳定性,为工业用途提供了一种经济高效的解决方案。

相似文献

1
Toward the Development of a Biosimilar Variant of Glucarpidase (Carboxypeptidase G2): Secretory Production, Optimization, and Immobilization.朝着开发羧肽酶G2(卡泊酸酶)的生物类似物变体迈进:分泌表达、优化及固定化
Mol Biotechnol. 2025 Jun 4. doi: 10.1007/s12033-025-01450-4.
2
Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy.葡糖醛酸酶(羧肽酶 G2):生物技术生产、作为氨甲喋呤解毒剂的临床应用,以及在靶向癌症治疗中的应用。
Biomed Pharmacother. 2023 Oct;166:115292. doi: 10.1016/j.biopha.2023.115292. Epub 2023 Aug 12.
3
Soluble expression, purification and functional characterisation of carboxypeptidase G2 and its individual domains.羧肽酶G2及其各个结构域的可溶性表达、纯化与功能表征
Protein Expr Purif. 2016 Nov;127:44-52. doi: 10.1016/j.pep.2016.06.015. Epub 2016 Jul 1.
4
Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.减毒沙门氏菌将前药激活酶羧肽酶G2靶向小鼠黑色素瘤以及人乳腺癌和结肠癌,以进行有效的自杀基因治疗。
Clin Cancer Res. 2008 Jul 1;14(13):4259-66. doi: 10.1158/1078-0432.CCR-07-4800.
5
Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment.新型葡糖醛酸酶的分离与分子特征:用于改善抗体导向酶前药疗法治疗癌症的酶。
PLoS One. 2018 Apr 26;13(4):e0196254. doi: 10.1371/journal.pone.0196254. eCollection 2018.
6
Coupling of a Novel TIMP3 Peptide to Carboxypeptidase G2 for Pro-Drug Activation at the Tumour Site.新型 TIMP3 肽与羧肽酶 G2 的偶联用于肿瘤部位前药激活。
Molecules. 2021 Jan 25;26(3):625. doi: 10.3390/molecules26030625.
7
Engineering carboxypeptidase G2 circular permutations for the design of an autoinhibited enzyme.设计用于自抑制酶的工程化羧肽酶G2环状排列体。
Protein Eng Des Sel. 2017 Apr 1;30(4):321-331. doi: 10.1093/protein/gzx005.
8
Detection of the prodrug-activating enzyme carboxypeptidase G2 activity with chemical exchange saturation transfer magnetic resonance.利用化学交换饱和转移磁共振检测前药激活酶羧肽酶G2的活性。
Mol Imaging Biol. 2014 Apr;16(2):152-7. doi: 10.1007/s11307-013-0680-5.
9
Functional overexpression and purification of a codon optimized synthetic glucarpidase (carboxypeptidase G2) in Escherichia coli.在大肠杆菌中功能过表达和纯化优化密码子的合成葡糖醛酸酶(羧肽酶 G2)。
Protein J. 2009 Dec;28(9-10):435-42. doi: 10.1007/s10930-009-9211-2.
10
Targeting Folates by Carboxypeptidase G2: Potential Applications in Anticancer Therapy.羧肽酶G2靶向叶酸:在抗癌治疗中的潜在应用
Onkologie. 2000 Dec;23(6):538-543. doi: 10.1159/000055003.

本文引用的文献

1
Efficiently scaled-up production of recombinant human elastin-like polypeptides using multiple optimization strategies.使用多种优化策略高效扩大重组人弹性蛋白样多肽的生产规模。
J Biotechnol. 2025 May;401:32-47. doi: 10.1016/j.jbiotec.2025.02.010. Epub 2025 Feb 20.
2
Comprehensive insight into exploring the potential of microbial enzymes in cancer therapy: Progress, challenges, and opportunities: A review.全面深入探讨微生物酶在癌症治疗中的潜力:进展、挑战与机遇:综述。
Int J Biol Macromol. 2024 Oct;277(Pt 4):134535. doi: 10.1016/j.ijbiomac.2024.134535. Epub 2024 Aug 5.
3
The Scr and Csc pathways for sucrose utilization co-exist in , but only the Scr pathway is widespread in other .
蔗糖利用的Scr和Csc途径在……中共存,但只有Scr途径在其他……中广泛存在。
Front Microbiol. 2024 Jul 3;15:1409295. doi: 10.3389/fmicb.2024.1409295. eCollection 2024.
4
Hydrogel Encapsulation Techniques and Its Clinical Applications in Drug Delivery and Regenerative Medicine: A Systematic Review.水凝胶包封技术及其在药物递送和再生医学中的临床应用:一项系统综述。
ACS Omega. 2024 Jun 24;9(27):29139-29158. doi: 10.1021/acsomega.3c10102. eCollection 2024 Jul 9.
5
Genome-scale models of metabolism and expression predict the metabolic burden of recombinant protein expression.基于代谢和表达的基因组规模模型预测了重组蛋白表达的代谢负担。
Metab Eng. 2024 Jul;84:109-116. doi: 10.1016/j.ymben.2024.06.005. Epub 2024 Jun 15.
6
Proteomics and metabolic burden analysis to understand the impact of recombinant protein production in E. coli.蛋白质组学和代谢负担分析,以了解重组蛋白在大肠杆菌中的生产的影响。
Sci Rep. 2024 May 28;14(1):12271. doi: 10.1038/s41598-024-63148-y.
7
"Metabolic burden" explained: stress symptoms and its related responses induced by (over)expression of (heterologous) proteins in Escherichia coli.“代谢负担”解析:大肠杆菌中(过)表达(异源)蛋白所诱导的应激症状及其相关反应。
Microb Cell Fact. 2024 Mar 30;23(1):96. doi: 10.1186/s12934-024-02370-9.
8
Escherichia coli as a versatile cell factory: Advances and challenges in recombinant protein production.大肠杆菌作为一种多功能细胞工厂:在重组蛋白生产中的进展和挑战。
Protein Expr Purif. 2024 Jul;219:106463. doi: 10.1016/j.pep.2024.106463. Epub 2024 Mar 12.
9
An Overview of Biosimilars-Development, Quality, Regulatory Issues, and Management in Healthcare.生物类似药概述——医疗保健领域的研发、质量、监管问题及管理
Pharmaceuticals (Basel). 2024 Feb 11;17(2):235. doi: 10.3390/ph17020235.
10
Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia.利用工程化的结肠定植型大肠杆菌 Nissle 1917 检测和治疗结直肠肿瘤。
Nat Commun. 2024 Jan 20;15(1):646. doi: 10.1038/s41467-024-44776-4.